CSTL
Castle Biosciences, Inc. · Healthcare · Medical - Diagnostics & Research
动量输入（同类管理人）：
持有人广度 -7.1% ·
股份流向 -0.9% ·
净新建仓位 -7.7%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | -1 | 16.83M | $401.45M | +6 | −6 |
| Q1 2026 | 79 | -9 | 16.13M | $395.93M | +4 | −13 |
| Q4 2025 | 87 | +2 | 17.12M | $665.58M | +2 | n/a |
| Q3 2025 | 16 | 0 | 9.41M | $214.29M | +1 | −1 |
| Q2 2025 | 13 | -1 | 9.39M | $191.81M | n/a | −1 |
| Q1 2025 | 11 | 0 | 4.13M | $82.76M | +1 | −1 |
| Q4 2024 | 11 | +2 | 4.84M | $128.97M | +4 | −2 |
| Q3 2024 | 8 | 0 | 2.64M | $75.25M | n/a | n/a |
| Q2 2024 | 8 | n/a | 1.95M | $42.47M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 3.15M | n/a | $64.42M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 2.17M | n/a | $44.31M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Citadel Advisors ✦ | 888.51K | +243.9% | $18.14M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (被动) | 707.69K | -1.0% | $14.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 689.93K | +6.2% | $14.09M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Renaissance Technologies ✦ | 670.50K | -4.4% | $13.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Millennium Management ✦ | 428.40K | +68.2% | $8.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 407.21K | -50.9% | $8.32M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 9 | D. E. Shaw & Co. ✦ | 148.19K | -21.7% | $3.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 49.23K | -64.1% | $1.01M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 11 | Two Sigma Investments ✦ | 28.24K | -79.8% | $576,681 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 26.41K | +11.4% | $540,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 24.00K | n/a | $490,080 | 0.0% | n/c | 1 | SEC ↗ ×3 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $4.73M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 186 持有人, 27.52M 股份, $653.08M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 3.29K 股 · $110,608
Officer, Director · 2.72K 股 · $96,668
Officer, Director · 3.20K 股 · $113,740
Officer, Director · 8.58K 股 · $305,156
Officer · 2.81K 股 · $100,350
Officer · 1.35K 股 · $48,967
Officer · 1.03K 股 · $35,363
Officer · 5.54K 股 · $196,765
Officer, Director · 2.72K 股 · $96,038
Officer, Director · 3.20K 股 · $112,998
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论